Stockreport

Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases [Yahoo! Finance]

Monte Rosa Therapeutics, Inc.  (GLUE) 
PDF Novartis also receives options to license two programs from Monte Rosa's growing preclinical immunology portfolio Monte Rosa to receive an upfront payment of million, [Read more]